Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.39 |
| ▸ | CYP11B2 | P19099 | 7/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.39 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.39 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.39 |
| ▸ | HSD17B3 | P37058 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13623258 | 0.88 | HPGD (0.41) | HPGDCYP11B1CYP11B2ADRA2AADRA2B | |
| SCHEMBL13623253 | 0.87 | HSD17B3 (0.48) | HPGDCYP11B1CYP11B2ADRA2AADRA2B | |
| SCHEMBL13623257 | 0.85 | ALDH1A1 (0.47) | HPGDCYP11B1CYP11B2HSD17B3ALDH1A1 | |
| SCHEMBL13158706 | 0.80 | HSD17B3 (0.41) | HPGDCYP11B1CYP11B2ADRA2AADRA2B | |
| SCHEMBL14281334 | 0.80 | HPGD (0.59) | HPGDADRA2AADRA2BADRA2CHSD17B3 | |
| SCHEMBL13408731 | 0.79 | HPGD (0.37) | HPGDCYP11B1CYP11B2ADRA2AADRA2B | |
| SCHEMBL13899986 | 0.78 | CYP11B1 (0.38) | HPGDCYP11B1CYP11B2ADRA2AADRA2B | |
| SCHEMBL14155275 | 0.76 | HPGD (0.45) | HPGDADRA2AADRA2BADRA2CGAA | |
| SCHEMBL2208353 | 0.76 | HPGD (0.46) | HPGDADRA2AADRA2BADRA2CHSD17B3 | |
| SCHEMBL6123811 | 0.76 | HPGD (0.56) | HPGDADRA2AADRA2BADRA2CHSD17B3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7619246-B2 | Organic light emitting compound and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-11-17 | — | — | US | disclosed |
| US-7619246-B2 | Organic light emitting compound and organic light emitting device comprising the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2009-11-17 | — | — | US | disclosed |
| US-20070176541-A1 | Organic light emitting compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-08-02 | — | — | US | disclosed |
| US-20070176541-A1 | Organic light emitting compound and organic light emitting device comprising the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2007-08-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070176541-A1 | Organic light emitting compound and organic light emitting device comprising the same | C1S, OR10J3, C1R | HPGD 3468/4885CYP11B1 910/4885CYP11B2 1100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.